Financings in Brief: Closure Medical
This article was originally published in The Gray Sheet
Executive Summary
Closure Medical: Medical tissue cohesive products firm completes secondary offering of 1.5 mil. shares at $12.875 per share, including 700,000 offered by a selling shareholder and 800,000 offered by the company ("The Gray Sheet" March 17, p. 11). Underwriters Lehman Brothers, Oppenheimer & Co. and Sands Brothers & Co. have an over-allotment option for 225,000 additional shares...
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.